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The intestinal epithelium forms a barrier between the microbiota and the rest of the body. In 
addition, beyond acting as a physical barrier, the function of intestinal epithelial cells (IECs) in 
sensing and responding to microbial signals is increasingly appreciated and likely has 
numerous implications for the vast network of immune cells within and below the intestinal 
epithelium. IECs also respond to factors produced by immune cells, and these can regulate 
IEC barrier function, proliferation and differentiation as well as influence the composition of 
the microbiota. The mechanisms involved in IEC-microbe-immune interactions, however, are 
not fully characterised. In this review, we explore the ability of IECs to direct intestinal 
homeostasis by orchestrating communication between intestinal microbes and mucosal innate 
and adaptive immune cells during physiological and inflammatory conditions. We focus 
primarily on the most recent findings and call attention to the numerous remaining unknowns 




The mucosal surface of the gastrointestinal (GI) tract consists of a single layer of intestinal 
epithelial cells (IECs) that provide an interface for immune cells to detect and respond to 
environmental substances. These include food components and pathogenic or commensal 
microbial species of archaea, bacteria, fungi, viruses and parasites, with around 1011 bacteria 
colonising the human GI tract 1. This creates an enormous source of potential immune stimuli; 
however, under homeostatic conditions the immune cells in and underlying the mucosa 
develop and function in a controlled manner, balancing inflammatory and regulatory 
responses to prevent overreaction to innocuous luminal antigens. During pathogenic infection, 
immune cells are mobilised to fight and clear invading microbes. While the mechanisms that 
regulate intestinal immune responses during health and disease are still being elucidated, 
dialogue between intestinal microbes, IECs and innate and adaptive immune cells is 
increasingly appreciated to play a major role.  
 
The IEC monolayer is composed of a number of cell types which differentiate from epithelial 
stem cells residing in the crypts. IEC types include goblet cells that produce mucin 
glycoproteins and form mucus, absorptive enterocytes, enteroendocrine cells, Paneth cells at 
the bottom of intestinal crypts that secrete antimicrobial peptides (AMPs), microfold (M) cells 
involved in antigen capture and presentation to immune cells, and tuft cells that promote type 
2 immunity to intestinal parasites 2, 3. Single cell RNA sequencing has further defined the 
behaviour and characteristics of each IEC cell type 4, and a recent study identified two 
subtypes of tuft cells which change in frequency during helminth infection 5. Together, IECs 
form the boundary between the internal body and outside environment, and studies in germ-
free mice have demonstrated that microbial colonisation of the intestinal lumen influences IEC 
metabolism, proliferation, survival, barrier function and communication with immune cells 6. 
IECs are the main cell type in direct contact with stimuli from the luminal microbiota and are 
critical players in microbe-host interactions. As such, in addition to epithelial cell-mediated 
defence mechanisms, IECs also coordinate the development and maturation of downstream 
 
 
immune responses from immune cells residing in the lamina propria and underlying lymphoid 
tissues. These immune cells help to contain microbes at the mucosa and maintain intestinal 
homeostasis.  
      
Although much is known about the immune cell populations in the gut, less is known about 
the mechanisms by which IECs regulate the development and maturation of immune cells 
during homeostasis and how this is disrupted during different disease states. In addition, the 
stimuli from commensal bacterial species recognised by IECs and the receptors and signalling 
pathways involved are not thoroughly understood. In this review, we describe the role of IECs 
as important communication hubs and modulators that shape and coordinate the activity of 
both microbes and immune cells. We place special emphasis on the most recent findings and 
highlight the many open questions regarding the complex network of interactions between 
IECs, the microbiota and intestinal immune cells. 
      
Microbiota-IEC crosstalk 
 
The intestinal epithelium is a highly dynamic tissue that provides both physical and chemical 
barriers to protect the intestinal mucosa and peripheral organs from commensal microbes or 
invading pathogenic microorganisms. In addition to forming a barrier, IECs also detect a 
myriad of signals from intestinal microbes, allowing fine tuning of IEC proliferation and 
homeostatic functions (Figure 1). Likewise, IEC programs can influence the composition of 
the intestinal microbiota in a number of ways.  
 
Microbial regulation of IEC growth and function 
 
IECs possess a number of mechanisms to sense and respond to the presence and activity of 
intestinal microbes. IECs express pattern recognition receptors (PRRs) to specifically detect 
molecular patterns from commensal and pathogenic gut microbes, and these have been 
extensively described in previous reviews 7-9. Following detection of intestinal microbes, IECs 
enhance various components of the intestinal barrier to protect underlying host tissues from 
bacterial infiltration. These include AMP production, mucus secretion, tight junction integrity, 
and IEC growth and differentiation. IECs secrete a range of AMPs, many through 
PRR/MyD88-dependent mechanisms, that accumulate in the mucus layer and possess broad 
antimicrobial activities 10, 11. Indeed, during C. rodentium infection, MyD88 signalling solely in 
IECs was recently shown to be sufficient to enhance IEC barrier integrity and increase 
production of RegIIIγ and immunomodulatory acute phase protein serum amyloid A1 (SAA1) 
12. Goblet cells secrete mucin glycoproteins to create the viscous mucus layer, and the 
importance of mucus in protection against invading microbes was recently highlighted in a 
study showing that the discontinuous mucus layer in the mouse cecum and corresponding 
uncovered areas of the epithelium form hotspots for Salmonella infection 13. A number of 
bacterial species have been shown to modulate mucin secretion by goblet cells. For example, 
commensal Ruminococcus gnavus 14 and Lactobacillus rhamnosus 15 stimulate the production 
of mucins, while pathogenic microbes including adherent and invasive E. coli promote a less 
effective mucus barrier 16. In a recent study, Amuc_1100, a membrane protein from 
commensal Akkermansia muciniphila, was shown to interact with the PRR Toll-like receptor 2 
(TLR2) to increase intestinal barrier function, namely mucus thickness and tight junction 
protein (TJP) expression 17.  
 
Although PRR-mediated mechanisms of sensing microbial products are the most extensively 
studied, IECs also utilise a number of other pathways. For example, inflammasomes have 
been shown to play an important role in IEC-sensing of microbial stimuli and damage-
associated molecular patterns (DAMPs) and in triggering protective barrier responses 18-21. 
The NAIP-NLRC4 inflammasome has recently been implicated in the IEC response to 
Salmonella infection in vivo, enabling proinflammatory programs that result in production of 
cytokines and the hormone-like eicanosoid prostaglandin PGE2, as well as lytic cell death and 
 
 
the expulsion of infected IECs 22. The autophagy pathway has also been shown to be critical 
for maintaining intestinal epithelial integrity in response to microbes, and a recent study 
demonstrated that release of lysozyme  by Paneth cells during bacterial infection is mediated 
through an autophagy-based alternative secretion pathway 23. Although mechanisms of 
microbial modulation of and sensing by IECs continue to be uncovered, many pathways likely 
remain incompletely characterised. 
 
Microbial metabolites produced by bacterial fermentation of dietary components are also 
important signals detected by IECs. For example, tryptophan catabolites, detected by 
pregnane X receptor (PXR)24 and the aryl hydrocarbon receptor (AhR) 25, 26, drive a multitude 
of anti-inflammatory and protective barrier functions. IEC AhR sensing of dietary components 
and tryptophan catabolites contributes to the maintenance of intestinal barrier integrity by 
inducing IEC differentiation from crypt stem cells 26 and mitigating inflammatory responses 27.  
PXR was recently shown to respond to indole 3-propionic acid (IPA), a tryptophan metabolite 
produced by commensal Clostridium sporogenes, and mice deficient for PXR exhibited 
increased epithelial inflammatory injury and decreased TJP expression. By contrast germ-free 
mice colonised with C. sporogenes and dosed with L-tryptophan exhibited decreased 
intestinal permeability and increased expression of detoxifying PXR target genes 24. In addition 
to serving as a major energy source for enterocytes, microbiota-derived SCFAs have also 
been implicated in the regulation of most IEC functions including cell turnover 28, tight junction 
protein expression 29, and inflammasome- or  HIF-mediated epithelial integrity 30, 31. SCFAs 
can directly influence gene transcription by binding to and inhibiting HDACs or through binding 
to the metabolite-sensing receptors GPR41, GPR43 and GPR109A 32. Indeed, a recent study 
showed that optimal expression of AMPs requires IEC sensing of SCFAs via GPR43. Using 
Gpr43-/- mice and enteroids, investigators observed that the AMPs RegIIIγ and β-defensins 
1, 3, and 4 were reduced in the absence of GPR43 or downstream mTOR and STAT3 
activation 33.  
 
Microbes also induce a number of non-barrier functions in IECs, including changes in 
metabolism and the biosynthesis of signalling molecules. For example, early during C. 
rodentium infection, IECs have recently been shown to exhibit changes in cholesterol and 
carbon metabolic pathways, suggesting that IEC metabolism is reprogrammed to meet 
increased cellular energetic demands during tissue repair 34. Some enterochromaffin cells, a 
subtype of enteroendocrine cell, have been shown to secrete serotonin (5-hydroxytryptamine, 
5-HT) in response to mechanosensing via the mechanotransducer Piezo2 35, and 5-HT is an 
important regulator of enteric nervous system development and GI tract motility and 
inflammation 36. In addition to mechansensing, a recent study demonstrated that several 
metabolites from a consortium of commensal spore-forming bacteria (predominantly 
Clostridial species) promote 5-HT biosynthesis by colonic enterochromaffin cells in colonised 
mice 37. In response to microbes, IECs also secrete a number of cytokines and effector 
molecules including IL-25 and SAA 38, 39. These effectors regulate the development and 
function of intestinal immune cells, as described in the next section of this review. Collectively, 
these recent findings indicate that a broad range of IEC functions are affected by sensing of 
intestinal microbes (Table 1); however, it is worth noting that many of these studies were 
performed in the context of pathogenic microbial infection. Further studies are required to 
identify additional stimuli from commensal microbes and charcterise commensurate IEC 
responses at steady state. 
 
Influence of IECs on diversity and function of the intestinal microbiota  
 
While the effects of IEC-microbe crosstalk on IECs are beginning to be elucidated, the effects 
of this interaction on the gut microbiota are substantially less characterised. Still, numerous 
recent studies have indicated that IECs also have an impact on the microbial populations 
residing in the gut. Autophagy is particularly well studied in maintaining the function of Paneth 
cells and protecting against pathogenic bacteria 40-44. Recently, disruption of IEC autophagy 
 
 
has also been shown to dramatically alter the composition of the gut microbiota and reduce 
intestinal microbial alpha diversity in mice 45. Another recent study showed that serotonin 
production by enterochromaffin cells modulates gut microbial composition 46, and AMPs 
secreted by IECs have been broadly reported to influence the composition of intestinal gut 
microbes 47-49. The NLRP6-inflammasome is also highly expressed by IECs, and previous 
studies have shown that NLRP6 helps maintain eubiosis of the intestinal microbiota 50, 51. 
However, recent studies of Nlrp6-/- and Asc-/- mice co-housed with wild-type littermates report 
that the NLRP6 inflammasome does not affect gut microbial diversity 52, 53, highlighting that 
non-genetic confounding factors may impact in vivo studies investigating causal relationships 
between host gene deficiencies and alterations in the microbiota 54. Indeed, while previous 
studies eliminated a role for NOD1 and NOD2 in shaping microbiota composition based on 
PCR for 10 targeted bacterial groups in co-housed littermates of different genotypes 55, NOD2 
signalling in IECs was recently strongly implicated in specifically controlling the colonisation 
and growth of commensal Bacteriodes vulgatus 56. In this recent study, while WT animals co-
housed with Nod2-/- mice acquired the overabundance of B. vulgatus characteristic of 
knockout mice, this was diminished upon re-separation. Given these conflicting observations, 
a strong case has been made for using crosses and littermate controls as a superior 
alternative (or addition) to co-housing 57. Still, the effects of IEC PRRs on the composition of 
the intestinal microbiota remain contentious, and importantly, the mechanisms behind many 
of the microbiota alterations observed have not been fully uncovered.  
 
Microbial gene expression is also influenced by IECs through several mechanisms. For 
instance, a recent study utilising IEC-specific TLR4 knockout (TLR4IEC-KO) mice demonstrated 
that TLR4 influences the composition and function of intestinal microbes, including the 
expression of microbial genes involved in the metabolism of lipids, amino acids and 
nucleotides 58. TLR4IEC-KO mice developed metabolic syndrome, and lysozyme and genes 
regulated by peroxisome proliferator-activated receptors (PPARs) were down-regulated, 
suggesting a mechanism by which intestinal TLR4 may influence the microbiota. In another 
study, attaching and effacing enterohemorrhagic E. coli was shown to require 
mechanosensing of IECs to express the locus of enterocyte effacement (LEE) that encodes 
its type 3 secretion system, and this was responsible for forming lesions in the GI tract 59. In 
addition, a recent study reported that miRNA is released by IECs into the intestinal lumen 
where it enters bacterial species such as F. nucleatum and E. coli and regulates their gene 
expression and growth 60. 
 
The main nutrient source for gut microbes is typically diet-derived components including 
polysaccharides or glycans. However, some gut microbes can also utilise host glycans on 
mucin proteins and the surface of IECs, providing an alternative energy source when dietary 
glycans are reduced 61-63. For example, several commensal Clostridiales members utilise the 
mucin-associated sugars fucose and sialic acid as energy sources, promoting their 
colonisation of the gut 27. Glycans are also ligands for bacterial attachment, and some gut 
microbial species such as Ruminococcus gnavus are hypothesised to target mucin glycans to 
assist their spread and persistence in niches in the intestinal lumen 64. Together, these studies 
demonstrate the multitude of interactions between microbes and IECs that can trigger various 
IEC programs and shape the microbial ecosystem in the gut. 
 
IEC-immune cell crosstalk 
While IECs possess a number of independent barrier functions to control and/or kill gut 
microbes, they also mediate crosstalk between the microbiota and intraepithelial and 
subepithelial immune cells by responding to microbial metabolites and coordinating immune 
responses. This is achieved by a number of known and unknown mechanisms including the 
secretion of chemokines, cytokines and other immunomodulatory molecules (Figure 2), as 
well as the transport of microbial antigens and metabolites to underlying immune cells in the 
 
 
lamina propria. Reciprocally, intestinal immune cells support a number of important IEC 
functions (Figure 3). 
IEC secretion of immunomodulatory molecules 
 
Among the immunomodulatory molecules that are produced by IECs, thymic stromal 
lymphopoietin (TSLP), transforming growth factor beta (TGF-b), retinoic acid (RA) and 
interleukin 10 (IL-10) have been shown to impact a broad range of immune cells and have 
each earned their own detailed reviews 65-68. In addition to these well-described modulators of 
immune cell function, IEC production of IL-15 has recently been shown to be required for the 
homing of protective TCRgd+ intraepiethlial lymphocytes (IELs) to the epithelium of the small 
intestine 69. TCRgd+ IEL surveillance behaviour, antimicrobial responses and protection 
against pathogens such as Salmonella Typhimurium and Toxoplasma gondii are dependent 
on MyD88 signalling in IECs 70, 71; however the mechanisms of IEC-IEL communication 
required for these functions are still unknown. In response to colonisation by adherent 
microbes, IECs secrete SAAs, which promotes the functional maturation of RORgt+ T cells to 
IL-17-secreting Th17 cells 72, 73. This has been hypothesised to occur via mechanosensing of 
microbial contact, and a recent study has shown that in the case of SFB, the transfer of SFB 
antigens through IECs via microbial adhesion-triggered endocytosis (MATE) plays a pivotal 
role 74. Another recent study shows that epithelial sensing of dietary vitamin A through retinoic 
acid receptor b (RARb) is also required for IEC expression of SAAs 75.  
Perhaps less appreciated, glucocorticoids (GCs) and neurotransmitters are also abundantly 
produced by epithelial cells in the gut. GCs are well-known for their general anti-inflammatory 
effects, but beyond their production in adrenal glands, crypt IECs have been shown to release 
GCs in response to anti-CD3-mediated T cell activation, and IEC synthesis of GCs has been 
shown to control local inflammation and disease severity in a TNBS (2,4,6-Trinitrobenzene 
sulphonic acid) colitis model 76, 77. As almost all vertebrate cells express glucocorticoid 
receptors (GR) the effects of GCs are pleiotropic; however, T cell-specific responses to GCs 
have been shown to be involved in T cell homeostasis, and Treg-specific GR deficiency was 
recently shown to impair Treg capacity to prevent the induction of disease in a mouse model 
of IBD 78, 79. In addition, a recent study of mice with diminished GR responses revealed an 
IFN-specific gene signature in the gut that was abrogated by antibiotic treatment, indicating a 
role for the microbiota 80. While information regarding intestinal production of GCs continues 
to emerge, the stimuli involved and immune cell effects have yet to be fully elucidated. 
Similarly, although a monoamine neurotransmitter, serotonin is primarily produced in the 
intestines by enterochromaffin cells. As discussed earlier, a recent study using germ-free mice 
colonised with spore-forming bacteria identified a role for metabolites from commensal 
microbes in promoting serotonin biosynthesis by colonic enterochromaffin cells 37. Although 
the effects of serotonin on intestinal immune cells have not been completely characterised, 
most immune cells express the serotonin transporter (SERT), and there is evidence that 
functions as diverse as T cell activation, eosinophil trafficking and TNF-a-mediated 
inflammation are modulated by serotonin 81-83. 
IEC transport of microbial antigens and metabolites 
 
An important mechanism by which intestinal epithelial cells direct adaptive immune responses 
to gut microbes is by antigen sampling and presentation to immune cells underlying the 
epithelium. Specialised M cells are concentrated in the follicle-associated epithelium that 
overlies the luminal surface of Peyer’s patches and isolated lymphoid follicles (ILFs) of the 
small intestine. M cells directly take up antigens and intact microorganisms from the intestinal 
lumen and transport them in a unidirectional way for presentation to resident immune cells. 
 
 
Antigen sampling by M cells is likely the key initiator of intestinal IgA responses to commensal 
bacteria as mice with impaired M cell differentiation display decreased faecal secretory IgA 84. 
In addition to M cells, goblet cells contribute to antigen sampling by forming goblet cell-
associated antigen passages (GAPs) to deliver intestinal lumen antigens to CD103+ dendritic 
cells in the lamina propria 85. Regulation of GAPs may constitute a dynamic means of 
modulating intestinal immune responses. While small intestine goblet cells form GAPs in 
response to acetylcholine, colonic goblet cell sensing of commensal microbes via MyD88 
decreases their acetylcholine responsiveness and formation of GAPs to limit inflammatory 
immune responses to commensals 86. Timed control of GAPs during the pre-weaning phase 
has been implicated in Treg-mediated tolerance towards commensal bacteria 87, and during 
Salmonella infection IL-1b inhibits GAP formation, leading to decreased bacterial 
dissemination 88. 
Enterocytes also participate in antigen presentation by several processes. These include 
presentation of lipid antigens to natural killer T (NKT) cells via expression of CD1d, and IEC 
CD1d expression has been shown to suppress proinflammatory NKT cell functions thereby 
reducing intestinal inflammation 89. In addition, MHC class II has been shown to be 
constituitively expressed by IECs in the upper villi of the small intestine, and surface 
expression appears to be increased in IBD patients and in response to IFN-g 90-92. Reciprocally, 
IEC antigen presentation was shown to promote IFN-g secretion by CD4+ T cells in cocultures 
of normal T cells with IECs from IBD patients 93; however, more recent studies suggest that 
IFN-g-induced MHC class II expression on IECs plays a more anti-inflammatory role by 
promoting a tolerogenic ratio of Tregs to effector CD4+ T cells 94, 95. Still, the role of IEC antigen 
presentation in shaping intestinal immunity has not been thoroughly explored, and the intimate 
contact between the epithelium and commensal microbes provides ample opportunity for IECs 
to curate intestinal T cell responses. 
 
Immune cell contributions to IEC differentiation and function 
In addition to IECs regulating immune cell functions, several intestinal immune cell types 
influence IEC homeostasis and inflammatory responses (Figure 3). For example, in response 
to microbial metabolites such as tryptophan catabolites, type 3 innate lymphoid cells (ILC3s) 
produce cytokines that regulate barrier functions of IECs 25. ILC3s secrete IL-22, which 
promotes IEC homeostasis and repair and can induce AMPs to control the growth of both 
pathogenic and commensal microbes 96-98. IL-22 also affects the glycosylation of IEC surface 
proteins by inducing fucosyltransferase 2 (Fut2) expression, thereby enhancing host 
protection against S. Typhimurium 99. Mucin production by IECs is also increased by IL-22 
through the activation of STAT3 100, and tight junction proteins (TJPs) such as claudin-2 have 
recently been shown to be upregulated by IL-22, inducing diarrhoea and facilitating clearance 
of Citrobacter rodentium in a mouse model of enteric infection 101. 
Beyond ILC3s and IL-22, some other lymphoid cells also contribute to IEC responses. During 
parasitic infection, IECs secrete a number of cytokines which promote the expansion and 
activation of group 2 innate lymphoid cells (ILC2s) and basophils, including IL-33 and TSLP 
and IL-25 produced by tuft cells 2, 5, 102, 103. Reciprocally, activated ILC2s secrete IL-13, which 
promotes tuft and goblet cell differentiation and parasite clearance 3, 104. The signature 
cytokines secreted by Th17 cells (IL-17A, IL-17F and IL-22) can also induce IEC-mediated 
AMP secretion and reinforce IEC tight junctions 105-108. In addition, production of the growth 
factor FGF2 by Tregs has recently been shown to synergise with IL-17 to enhance 
mechanisms of intestinal epithelial repair 109. IEC responsiveness to TNF also promotes 
mucosal repair and healing in Crohn’s disease patients, human cells, and mouse models 110. 
 
 
Myeloid cells also play key roles in IEC differentiation and function. For instance, perturbations 
to macrophage-IEC interactions leads to aberrant differentiation of IEC subtypes. Using 
CSF1R blockade to deplete macrophages that localise to the intestinal crypt epithelium, a 
recent study found that absence of macrophages results in reduced Lgr5+ intestinal stem cells, 
lysozyme-expressing Paneth cells and Peyer’s patch M cells and increased goblet cell density 
111. Macrophages have also been shown to be the likely source of IL-10 in a colon biopsy–
induced injury model, and in this model macrophage IL-10 induced epithelial synthesis of the 
pro-repair WNT1-inducible signalling protein 1 (WISP-1) to mediate IEC proliferation and 
mucosal wound healing 112. In DCs, TGF-b signalling has been suggested to control goblet 
cell numbers, mucus production and disease severity in DSS colitis via Notch signalling, 
although the effects of DC dysfunction on and involvement of other immune cells types were 
not fully investigated in this study 113. More recently, IL-12 responsiveness via IL-12Rb2 on 
IECs has been shown to play a protective role in food allergy; however, the precise mechanism 
of protection is once again unknown 114. 
Immune cell-microbiota crosstalk 
 
Due to limited direct contact, most immune cell-microbiota communication is likely mediated, 
at least to some extent, by IECs; however, the contributions of IECs to many microbiota-
immune cell interactions have yet to be fully realised. Nevertheless, a growing body of work 
has revealed the importance of commensal microbes for the proper development and function 
of immune cells (Figure 4), and immune cells reciprocally shape the microbial habitat and 
microbiota diversity. 
 
Microbiota modulation of intestinal lymphocytes 
 
As mentioned earlier, the proper development of IL-17-secreting Th17 cells requires SAA 
production by IECs in response to microbial adhesion and specifically MATE in response to 
SFB adhesion. The human symbiont Bifidobacterium adolescentis, which closely associates 
with the gut epithelium, is also reported to induce Th17 cells in the murine intestine with a 
transcriptional program distinct from SFB, suggesting Th17 accumulation can also be 
promoted by another mechanism 115. While precise roles for IECs have not been completely 
defined, roles for commensal microbial metabolites and antigens also continue to emerge for 
the generation and function of Tregs. In three seminal studies, commensal-derived butyrate 
was shown to drive induction of peripheral Tregs in the colon 116-118. A later study also showed 
a role for recognition of antigens from commensal microbes in intestinal Treg differentiation. 
Transfer of naive transgenic T cells specific for commensal antigens into mice with a normal 
microbiota resulted in robust Foxp3 induction in these cells 119. At weaning, the intestinal 
microbiota induces a vigorous immune response associated with the generation of RORγt+ 
Tregs in a SCFA and RA-dependent manner, and inhibition of this response leads to later 
immunopathologies including colitis 120.  
 
RORgt+ Tregs specific for Helicobacter hepaticus have also been shown to mediate tolerance 
to this commensal pathobiont 121, and a polysaccharide from the same species induces anti-
inflammatory IL-10 secretion in intestinal macrophages 122. However, Helicobacter specificity 
itself does not dictate an anti-inflammatory program. A recent study demonstrated that the 
same Helicobacter-specific T cells differentiate to Tregs during homeostasis and effector T 
cells during colitis 123. Helicobacter bilis colonisation, on the other hand, has previously been 
shown to induce persistent immune reactivity to other commensal bacteria 124. Collectively, 
these studies suggest the importance of antigen-independent contextual cues during T cell 
activation in the gut for determining T cell fates. Indeed, two secondary bile acids, generated 
by commensal bacteria transformation of primary bile acids, were recently shown to inhibit 
Th17 differentiation and promote Treg induction 125. Identifying the full spectrum of contextual 




In addition to conventional T cells, IELs have proved to be markedly influenced by the 
commensal microbiota. For example, TCRab+ IELs are almost absent in GF mice 126, 127, and 
TCRgd+ IELs have impaired cytolytic activity 128. The mechanisms of this control are still under 
investigation, but they likely involve transmission of signals through the IECs. The gut 
microbiota is also an important factor in the generation of TCRab+CD4+CD8aa+ IELs. In a 
recent study, introduction of tryptophan-metabolising Lactobacillus reuteri in mice given a diet 
rich in tryptophan was sufficient to induce TCRab+CD4+CD8aa+ IEL differentiation 129. 
Another study has demonstrated microbiota-dependent conversion of lamina propria Foxp3+ 
Tregs into TCRab+CD4+CD8aa+ IELs upon homing to the intestinal epithelium 130. The ability 
of epithelial cells and microbial metabolites to contribute to the induction of this IEL subset is 
also still being elucidated. 
 
Immune cell effects on the intestinal microbiota 
 
While historically met with scepticism and comparatively understudied, influences of intestinal 
immune cells on the microbiota are also gaining appreciation. Evidence that the adaptive 
immune system shapes microbial composition and diversity in the gut has been provided using 
sequencing of bacteria in multiple intestinal loci in Rag-deficient mice that lack B and T cells 
131. However, while ILCs are present in Rag-deficient mice, there is evidence that their number 
and function are altered 132, complicating conclusions that can be drawn from these animals 
about the role of B and T cells. Further studies have identified an important role for polyreactive 
IgA in facilitating the induction of bacteria-specific IgA, and differences in these significantly 
influence colonisation by commensal microbes 133. Indeed, Bacteroides fragilis has now been 
shown to permit binding of IgA to facilitate its ability to occupy a privileged intestinal niche in 
close proximity to IECs 134. Very recently, an important role was identified for commensal-
specific IgG that results from epithelial disruption in the gut. Responsiveness to these IgGs in 
intestinal macrophages via activating FcγRs drives intestinal inflammation and colitis 135. 
Although the effects of these IgGs on microbiota composition have not yet been characterised, 
future studies may define functions for both intestinal IgA and IgG in modulating commensal 
microbial communities. 
 
Immune cells in the gut are tasked with maintaining a balance of physiological inflammation 
and tolerance. The resulting intestinal immune cell programs regulate the microbial ecosystem 
in the gut in a manner that allows for beneficial colonisation and deters invasive pathogenic 
infection. For example, Foxp3+ Tregs have been shown to support microbiota diversity both 
by suppressing inflammation and facilitating IgA selection in Peyer's patches 136. Conversely, 
a lack of peripheral Tregs leads to increased type 2 immune responses and disruption of 
microbial niches for IEC border-dwelling bacteria 137, highlighting the importance of these T 
cells in shaping the intestinal microbial environment. In addition to composition and diversity, 
the evolution of commensal bacterial species has also been shown to be influenced by host 
adaptive immunity. In the intestines of Rag-deficient mice, the rate and predictability of E. coli 
adaptation is altered in comparison to wild-type hosts 138. Taken together, these studies bring 
new insight into the intimate interdependence of the intestinal microbiota and immune system 





Due to the anatomical location of IECs between the intestinal microbiota and the host intestinal 
tissues, it is reasonable to predict that IECs play an important role in controlling the interaction  
between the luminal microbiota and underlying immune cells. Indeed, recent literature has 
highlighted the ability of IECs to contribute to shaping both host intestinal immunity and gut 
 
 
microbial composition. However, despite recent progress in the field, several challenges 
remain to be addressed and overcome.  
 
Demonstrating that IEC secreted factors are induced in response to microbe-derived signals, 
and the effects of these factors on immune cells has proved difficult. Most IEC-derived 
cytokines are also produced by other cell types, therefore IEC involvement in vivo is usually 
inferred but not definitively demonstrated. Knockout mice for certain receptors or effector 
molecules expressed by IECs have yielded further insight into the roles of IECs as direct 
sensors of microbial signals; however, few studies have employed IEC-specific genetic 
ablation in vivo. Studying the impact of microbe-IEC signalling on the function of immune cell 
subsets is also limited due to the difficulty in isolating and manipulating these cell types; the 
lifespan of IECs is extremely short as they are renewed every 2-6 days 139. Although in vitro 
models have provided valuable insight into IEC signalling pathways and production of 
effectors, they remain unable to recapitulate the complexity of the intestinal environment, and 
interpretation of these studies is consequently limited. By further elucidating the mechanisms 
involved in microbe-immune crosstalk at the intestinal epithelium, we can better understand 
the role of IECs in regulating host immunity during homeostasis as well as during states of 






Table 1. Gut microbial stimuli that interact with IECs. 
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Figure 1: IECs sense microbial stimuli through a number of different mechanisms that 
regulate IEC gene transcription and inflammatory responses. For example, tryptophan 
catabolites and SCFAs produced as a result of microbial metabolism trigger the activation of 
AhR, PXR, ERK1/2 and p38 that directly regulate the expression of target genes. The 
inflammasome complexes in IECs reported to respond to microbial stimuli include NLRP3, 
NAIP-NLRC4, NLRP6 and NLRP9b, which trigger cell death pathways and the release of 
inflammatory cytokines and mediators.  
 
Figure 2: In response to microbial stimuli IECs secrete factors which modulate various 
immune cell functions. In the small intestine these include IL-15, required for the recruitment 
of protective TCRgd+ IELs to the epithelial layer, and SAAs which induce the differentiation of 
IL-17-secreting Th17 cells. In the small and large intestine glucocorticoids and serotonin 
promote anti-inflammatory responses by immune cell populations, including lymphocytes 
and eosinophils, modulating inflammation and the development of disease pathology.  
 
Figure 3: Immune cells contribute to the regulation of IEC differentiation and barrier 
function. For example, ILC3 secretion of IL-22 regulates IEC secretion of AMPs and mucins, 
tight junction formation, and surface protein glycosylation, assisting in resistance to 
pathogenic microbes.  Tolerance to food antigens is reported to involve IEC responsiveness 
to IL-12; however, the subsequent IEC signaling pathways and immune cell types which 
mediate this response are not currently known.    
 
Figure 4: Microbial modulation of intestinal immune cells is reported to involve both direct 
interaction of lymphocytes and APCs with microbial stimuli, as well as relatively 
uncharacterised indirect interactions via IECs. These interactions involve many subsets of 
intraepithelial and lamina propria T cells and microbial metabolites like SCFAs, tryptophan 
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